Moderna shares surge 160%, delivering $5 billion loss to short sellers

Moderna's stock price surged 160%, resulting in a $5 billion loss for short sellers who had wagered on the company's continued decline. The dramatic rally caught bearish investors off guard, reversing years of pessimism about the vaccine maker's performance. This sharp reversal demonstrates the significant financial risks involved in short selling during market reversals.